Supplemental Statement – Mammalian Cell Culture-Based Influenza Vaccines

Agzul n yisemli ASEM

Official National Advisory Committee on Immunization document (2020) on “Supplemental Statement – Mammalian Cell Culture-Based Influenza Vaccines”. Flucelvax® Quad is a mammalian cell culture-based, inactivated seasonal influenza vaccine that has recently been authorized for use in Canada in adults and children ≥9 years of age.

Agzul-a ad k-yefk tallalt deg unadi ɣef uttaft. I wellihen klinik, ẓer yal tikkelt lqem unṣib amiran akked uzemz n uleqqem-is.